Publicaciones en las que colabora con MANUEL DÍAZ-RUBIO GARCÍA (38)

2014

  1. Need for infliximab dose intensification in Crohn's disease and ulcerative colitis

    World Journal of Gastroenterology, pp. 9170-9177

2012

  1. Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease

    Journal of Crohn's and Colitis, Vol. 6, Núm. 4, pp. 488-491

2011

  1. Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy

    European Journal of Internal Medicine, Vol. 22, Núm. 6, pp. 621-625

2010

  1. High prevalence of viable mycobacterium avium subspecies paratuberculosis in crohn's disease

    World Journal of Gastroenterology, Vol. 16, Núm. 36, pp. 4558-4563

  2. Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: A comparative analysis of nine scoring methods

    Scandinavian Journal of Gastroenterology, Vol. 45, Núm. 1, pp. 51-59

  3. Study of chromosomal region 5p13.1 in Crohn's disease, ulcerative colitis, and rheumatoid arthritis

    Human Immunology, Vol. 71, Núm. 8, pp. 826-828

2009

  1. Analysis of a non-synonymous single nucleotide polymorphism of the human diamine oxidase gene (ref. SNP ID: Rs1049793) in patients with Crohn's disease

    Scandinavian Journal of Gastroenterology, Vol. 44, Núm. 10, pp. 1207-1212

  2. Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility

    Genes and Immunity, Vol. 10, Núm. 7, pp. 631-635

  3. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease

    American Journal of Gastroenterology, Vol. 104, Núm. 8, pp. 1968-1975

  4. Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: A study in the spanish population and a meta-analysis

    Inflammatory Bowel Diseases, Vol. 15, Núm. 11, pp. 1697-1704

  5. Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15- Crohn's disease patients

    European Journal of Human Genetics, Vol. 17, Núm. 10, pp. 1304-1308

2008

  1. IL23R and IL12B polymorphisms in Spanish IBD patients: No evidence of interaction

    Inflammatory Bowel Diseases, Vol. 14, Núm. 9, pp. 1192-1196

  2. Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding

    Pharmacogenetics and Genomics, Vol. 18, Núm. 1, pp. 37-43

2007

  1. Epistatic interaction between FCRL3 and MHC in Spanish patients with IBD

    Tissue Antigens, Vol. 69, Núm. 4, pp. 313-317

  2. GSTT1 and GSTM1 null genotypes may facilitate hepatitis C virus infection becoming chronic

    Journal of Infectious Diseases, Vol. 195, Núm. 9, pp. 1320-1323

  3. Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility

    Immunogenetics, Vol. 59, Núm. 11, pp. 833-837

  4. MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease

    Inflammatory Bowel Diseases, Vol. 13, Núm. 5, pp. 585-590

  5. MYO9B polymorphisms in patients with inflammatory bowel disease [3]

    Gut

  6. Role of the PXR gene locus in inflammatory bowel diseases

    Inflammatory Bowel Diseases, Vol. 13, Núm. 12, pp. 1484-1487

  7. Utilidad de la biopsia hepática en el diagnóstico etiológico de las alteraciones de la analítica hepática de causa incierta

    Gastroenterologia y Hepatologia, Vol. 30, Núm. 6, pp. 325-330